Program

Korea Standard Time
Local Time

Invited Speakers




Plenary Lectures (PL)
Soonmyung Paik CV
Yonsei University College of Medicine
Things to consider in designing personalized cancer vaccines
Reuben Shaw CV
Salk Institute for Biological Studies, La Jolla, CA, USA
Decoding critical targets of the LKB1/STK11 Tumor Suppressor in NSCLC
Yung-Jue Bang CV
Seoul National University College of Medicine
Evolution of cancer treatment and development of Korean Cancer Association
Emile Voest CV
Netherlands Cancer Institute, Netherlands
How whole genome sequencing can advance precision medicine


Educational Sessions (ES)

ES1. Advanced modeling for predicting and enhancing radiotherapy response
6/20(Thu) 09:00-10:00
cv
Hojin Kim
Yonsei University College of Medicine
cv
WonMo Sung
The Catholic University of Korea College of Medicine
cv
Nitin Ohri
Montefiore Einstein Comprehensive Cancer Center

ES2. Hereditary and early-onset cancers
6/20(Thu) 09:00-10:00
cv
Sang-Ah Han
Kyung Hee University School of Medicine
cv
Koung Jin Suh
Seoul National University Bundang Hospital
cv
Tae-Min Kim
The Catholic University of Korea College of Medicine

ES3. Novel therapeutic targets to regulate tumor microenvironment
6/20(Thu) 15:30-17:10
cv
Su-Hyung Park
KAIST
cv
Rolf Brekken
UT Southwestern
cv
Jae-Hoon Chang
Yeungnam University College of Pharmacy
cv
Makoto Nakanishi
The University of Tokyo

ES4. Artificial intelligence for clinical data and big laboratory data
6/21(Fri) 09:00-10:40
cv
Dongwan Hong
The Catholic University of Korea College of Medicine
cv
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
cv
Kyu-Hwan Jung
Samsung Advanced Institute for Health Sciences & Technology
cv
Soon Ho Yoon
Seoul National University College of Medicine

ES5. Evolution of the WHO classifications of tumors in the molecular era
6/21(Fri) 09:00-10:40
cv
Se Hoon Kim
Yonsei University College of Medicine
cv
Yoon Kyung Jeon
Seoul National University College of Medicine
cv
Puay Hoon Tan
Luma Medical Centre
cv
Kyoung-Mee Kim
Sungkyunkwan University School of Medicine

ES6. Perioperative MDT approach for advanced cancer
6/21(Fri) 14:30-16:10
cv
Hye Seung Lee
Seoul National University College of Medicine
cv
Chang Young Lee
Yonsei University College of Medicine
cv
Sehhoon Park
Samsung Medical Center
cv
Sung Uk Lee
National Cancer Center

ES7. Treatment approach through tracking ctDNA
6/21(Fri) 16:30-17:30
cv
Seung-Tae Lee
Yonsei University College of Medicine
cv
Eiji Oki
Graduate School of Medical Sciences, Kyushu University
cv
Wonyoung Choi
National Cancer Center


Symposia (SP)

SP01. Next-generation therapeutics for oncogene-driven cancers
6/20(Thu) 09:00-10:00
cv
Eun Joo Kang
Korea University College of Medicine
cv
Hee Kyung Ahn
Gachon University College of Medicine
cv
Sae-Won Han
Seoul National University College of Medicine

SP02. Preventing and monitoring Asian cancers
* Joint Symposium of KCA & China Anti-Cancer Association (CACA)
6/20(Thu) 13:30-15:10
cv
Kyoung-Nam Kim
Yonsei University College of Medicine
cv
Kexin Chen
Tianjin Medical University Cancer Institute & Hospital
cv
Daehee Kang
Seoul National University College of Medicine
cv
Wen-Qing Li
Peking University Cancer Hospital

SP03. Early cancer detection and cancer prevention
in the molecular era
6/20(Thu) 13:30-15:10
cv
Sun-Young Kong
National Cancer Center
cv
Boyoung Park
Hanyang University College of Medicine
cv
Jee-Soo Lee
Seoul National University College of Medicine
cv
Pan-Chyr Yang
National Taiwan University College of Medicine

SP04. Oligometastasis
6/20(Thu) 13:30-15:10
cv
Chai Hong Rim
Korea University College of Medicine
cv
Kyung Hwan Kim
Yonsei University College of Medicine
cv
Jang Ho Cho
The Catholic University of Korea College of Medicine
cv
Sarah Baker
University of British Columbia

SP05. Next-generation precision oncology
* Joint Symposium of KCA & Japanese Cancer Association (JCA)
6/20(Thu) 15:30-17:10
cv
Yoon Ji Choi
Korea University College of Medicine
cv
Takashi Kohno
National Cancer Center Japan
cv
Jeonghwan Youk
Seoul National University Hospital
cv
Motohiro Kato
The University of Tokyo

SP06. Recent update in pediatric-type sarcoma
* Joint Symposium of KCA & Korean Society of Pediatric Hematology-Oncology (KSPHO)
6/20(Thu) 15:30-17:10
cv
Jung Sun Kim
Sungkyunkwan University School of Medicine
cv
Han-Soo Kim
Seoul National University College of Medicine
cv
Jun Ah Lee
National Cancer Center
cv
Seo Hee Choi
Yonsei University College of Medicine

SP07. Informatics in Oncology 2024
6/20(Thu) 15:30-17:10
cv
Jong Bae Park
National Cancer Center Graduate School of Cancer Science and Policy
cv
Eun-Hye Shim
Ministry of Health and Welfare
cv
Hee Hwang
Kakao Healthcare
cv
Wonbok Lee
Ewha Womans University
cv
Hwa Kim
Ewha Womans University

SP08. Next-generation antibody and cellular therapies
in immuno-oncology
* Joint Symposium of KCA & Korean Association of Immunologists (KAI)
6/21(Fri) 09:00-10:40
cv
Sun Min Lim
Yonsei University College of Medicine
cv
Ho Min Kim
KAIST
cv
Chan Hyuk Kim
Seoul National University School of Transdisciplinary Innovations
cv
Hyungseok Seo
Seoul National University College of Pharmacy

SP09. Understanding and targeting genomic instability
* Joint Symposium of KCA & Cancer Science Institute of Singapore (CSI Singapore)
6/21(Fri) 14:30-16:10
cv
Young Seok Ju
KAIST
cv
Ashok Venkitaraman
National University of Singapore
cv
Taejoon Kwon
UNIST
cv
David SP Tan
National University of Singapore

SP10. Functional genomics for novel targets
Joint Symposium of KCA & Korea Genome Organization (KOGO)
6/21(Fri) 14:30-16:10
cv
Seon-Young Kim
Korea Research Institute of Bioscience and Biotechnology
cv
In-Ho Kim
The Catholic University of Korea College of Medicine
cv
Jihwan Park
GIST
cv
Shin Yup Lee
Kyungpook National University School of Medicine

SP11. 국가암진료 가이드라인 사업 성과와 발전 방안
6/21(Fri) 14:30-16:10
cv
Ho-Shin Gwak
National Cancer Center
cv
Soo Young Kim
Hallym University College of Medicine
cv
Hye Sook Han
Chungbuk National University Of Medicine
cv
Eun Kyung Lee
National Cancer Center
cv
Jung Myun Kwak
Korea University College of Medicine



Special Lecture (SPS)

KCA Golden Jubilee and Global Cancer Network
6/20(Thu) 13:30-14:50
cv
Tae You Kim
Seoul National University College of Medicine
cv
Takashi Kohno
National Cancer Center Japan
cv
Ying Wang
China Anti-Cancer Association
cv
Ashok Venkitaraman
National University of Singapore
cv
Elizabeth M. Jaffee
Johns Hopkins University School of Medicine, USA


Industry Corner (IC)

KCA-industry collaboration for future cancer research
- New modalities in cancer drug development
6/20(Thu) 13:30-15:10
cv
Jaewoo Kang
Korea University/AIGEN Sciences
cv
Byoung Chul Cho
Yonsei University College of Medicine
cv
Do-Hyun Nam
Samsung Medical Center/AimedBio
cv
Garima Sharma
ImmunoBiome


Overseas Korean Researcher Session (OS)

Overseas Korean Researcher Session
6/21(Fri) 14:30-15:45
cv
Chang Won Song
University of Minnesota
cv
Minah Kim
Columbia University
cv
Kyoung Eun Lee
University of Michigan


Young Investigator Symposium (YIS)

Young Investigator Symposium
6/21(Fri) 16:30-17:30
cv
Taek-Chin Cheong
Boston Children's Hospital and Harvard Medical School
cv
Duk Ki Kim
Chungnam National University Hospital
cv
Wungki Park
Memorial Sloan Kettering Cancer Center


Luncheon Symposia (LS)

Luncheon Symposium 1 (Boryung)
6/20(Thu) 12:20-13:00
Jii Bum Lee CV
Yonsei University College of Medicine
SCLC: New treatment paradigms and a glimpse into our treatment options of tomorrow
Luncheon Symposium 2 (MSD)
6/21(Fri) 12:30-13:10
Se-Hoon Lee CV
Sungkyunkwan University School of Medicine
Unlocking the door: A paradigm shift in early-stage NSCLC treatment with pembrolizumab


Satellite Symposia (SS)

Satellite Symposium 1 (Astellas)
6/20(Thu) 09:00-09:40
Hyung-Don Kim CV
University of Ulsan College of Medicine
CLDN18.2 targeting treatment for gastric cancer

Satellite Symposium 2 (Boryung)
6/21(Fri) 15:30-16:10
Chung Ryul Oh CV
Chung-Ang University Hospital
Pancreatic cancer: State-of-the-Art Neo/Adjuvant treatment in pancreatic cancer_ Guidance for oncologist

Satellite Symposium 3 (MSD)
6/21(Fri) 09:00-09:20
Jaekyung Cheon CV
University of Ulsan College of Medicine
A first-line treatment option for locally advanced unresectable or metastatic biliary track cancer

Satellite Symposium 4 (Lilly)
6/21(Fri) 09:20-10:00
Jieun Lee CV
The Catholic University of Korea College of Medicine
A journey to the hope of HR+/HER2- EBC&MBC patient: Abemaciclib new data

top